4th Quarter - Report

W STRATEGIES, LLC for ENOVIS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 523: Protect Medical Innovation Act of 2013.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 523 (113th)

Medicare/Medicaid MMM

General Medicare issues and legislation affecting durable medical equipment (DME) reimbursement and regulation, including the inclusion of Transcutaneous Electrical Nerve Stimulation (TENS) devices in the rebid of Round One of the Medicare competitive bidding program. H.R. 1761, S. 1318: HELLPP Act.Education with respect to DME proposals in the 2014 ESRD rule, specifically with respect to payment reclassification for bone growth stimulation devices and three year minimum lifetime requirement proposal for durable medical equipment (DME).

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1761 (113th), S. 1318 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.